Varonis price target raised to $39 from $38 at JPMorgan

JPMorgan analyst Brian Essex raised the firm’s price target on Varonis (VRNS) to $39 from $38 and keeps an Overweight rating on the shares. The company’s “beat-and-raise” results in a tough macro backdrop indicate the business is “headed in the right direction after its recent expectation reset,” the analyst tells investors in a research note. JPMorgan cites Varonis’ better results and outlook for the target bump.